ARTICLE | Financial News
DNAtrix raises $20M in series B
October 15, 2014 1:45 AM UTC
Cancer play DNAtrix Inc. (Houston, Texas) raised $20 million in an untranched series B round led by new investor Morningside Ventures. Existing investors Mercury Fund, Targeted Technology Fund and unnamed others also participated. Morningside's Reenie McCarthy joined DNAtrix's board. ...